Gerald Quirk
General Counsel at SYROS PHARMACEUTICALS, INC.
Net worth: 212 700 $ as of 30/03/2024
Profile
Gerald E.
Quirk is currently the Chief Legal Officer at Syros Pharmaceuticals, Inc. He previously worked as Co-Chairman-Life Sciences Group at Choate, Hall & Stewart LLP, Managing Corporate Counsel at Genzyme Corp., Secretary, VP-Corporate Affairs & General Counsel at Infinity Pharmaceuticals, Inc., and Executive VP-Business Operations & General Counsel at Tokai Pharmaceuticals, Inc. He also worked as an Associate-Business Law Department at Palmer & Dodge LLP.
Quirk received his undergraduate degree from Swarthmore College and his graduate degrees from Harvard University and Northeastern University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/03/2024 | 39,757 ( 0.15% ) | 212 700 $ | 30/03/2024 |
Gerald Quirk active positions
| Companies | Position | Start |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | General Counsel | - |
Former positions of Gerald Quirk
| Companies | Position | End |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Chief Administrative Officer | 28/02/2022 |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | General Counsel | 30/08/2016 |
Choate, Hall & Stewart LLP
 Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Choate, Hall & Stewart LLP provides legal services. It offers services in the areas of private equity, technology, intellectual property, mergers & acquisitions, commercial litigation, and insurance & reinsurance litigation. The company was founded in 1899 and is headquartered in Boston, MA. | Corporate Officer/Principal | 30/04/2015 |
| INFINITY PHARMACEUTICALS, INC. | Investor Relations Contact | 31/07/2012 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 31/08/2006 |
Training of Gerald Quirk
| Harvard University | Graduate Degree |
| Swarthmore College | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Choate, Hall & Stewart LLP
Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Choate, Hall & Stewart LLP provides legal services. It offers services in the areas of private equity, technology, intellectual property, mergers & acquisitions, commercial litigation, and insurance & reinsurance litigation. The company was founded in 1899 and is headquartered in Boston, MA. | Commercial Services |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Palmer & Dodge LLP | Commercial Services |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Gerald Quirk
